-
Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumab
Joshua R Veatch et al.,
Jitc, 2020
-
Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer.
Jara Palomero et al.,
Jitc, 2022
-
Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases
Marie Kroemer et al.,
Jitc, 2020
-
Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function
Hye Ryun Kim et al.,
Jitc, 2019
-
1036 Treg-specific TCR signaling as a target of cancer immunotherapy
Atsushi Tanaka et al.,
Jitc, 2023